RheumNow Live 2026

🔥 RheumNow Live 2026

Advanced Rheumatology & Autoimmune Disease Update

---

🎯 Product Description

Stay at the forefront of modern rheumatology with RheumNow Live 2026, a comprehensive clinical update covering the latest breakthroughs in rheumatic and autoimmune diseases.

This expert-led program delivers cutting-edge insights into diagnosis, management, and emerging therapies for conditions such as rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, gout, vasculitis, and Sjögren’s syndrome—helping clinicians translate the latest evidence into real-world practice.

📅 Course Date: February 7–8, 2026
🎥 Content: 43 Videos (.mp4) + 43 Subtitles (.vtt) + 29 PDFs
💾 Total Size: 27.63 GB

---

👨‍⚕️ Target Audience

Designed for:

• Rheumatologists
• Immunologists
• Physicians managing autoimmune and inflammatory diseases

---

📚 What You Will Learn

✔️ Evaluate the latest advances in rheumatoid arthritis, including ILD and the mucosal hypothesis
✔️ Apply updated strategies for axial spondyloarthritis, psoriatic arthritis (IL-23 vs IL-17), and gout
✔️ Understand evolving therapies for vasculitis and Sjögren’s syndrome
✔️ Manage comorbidities such as obesity and systemic inflammation
✔️ Reduce surgical risks in rheumatic patients undergoing orthopedic procedures
✔️ Explore emerging therapies and clinical innovations

---

🧠 Full Course Topics (43 Sessions)

🔬 Core Rheumatology & Disease Updates

• 2026 Advances in Spondyloarthritis
• Diagnosing Axial Spondyloarthritis in 2026
• Spondyloarthritis Complications
• Staying Ahead of Spondyloarthritis
• Rheumatoid Arthritis: Achieving Better Outcomes
• ILD in Rheumatoid Arthritis – Recent Advances
• Mortality in Rheumatoid Arthritis: Decline, Delay, or Plateau
• The Mucosal Hypothesis of Rheumatoid Arthritis
• Psoriatic Arthritis: IL-23 vs IL-17 Inhibitors
• Decisions in Psoriatic Arthritis
• Why Do Plain X-rays in Psoriatic Arthritis
• Paradoxical Psoriasis and Strange Reactions
• History of Gout
• Past, Present & Future of Gout

---

🧪 Autoimmune & Systemic Diseases

• Highlights in Autoimmune Disease
• Large & Small Vessel Vasculitis
• Small Vessel Vasculitis
• Sjögren’s Treatment Landscape in 2026
• Update on Myositis Antibodies

---

🫁 Comorbidities & Clinical Challenges

• Obesity and Inflammation in Rheumatology
• Orthopedic Surgery Risk Management
• Asymptomatic Elevation of CK
• Helicobacter pylori Update

---

🦴 Bone & Joint Disorders

• Disease Modification in Osteoarthritis
• Osteoporosis: A 50-Year Journey

---

💊 Treatments & Clinical Strategies

• SMILE Study – Hydroxychloroquine in ANA Arthralgia
• Placebos in Rheumatology
• PMR & GCA Relapse Management

---

🎤 Panels & Expert Discussions

• Rheumatoid Arthritis Q&A
• Psoriatic Arthritis Q&A
• Spondyloarthritis Q&A
• Vasculitis Q&A
• Autoimmune Disease Q&A
• Advancing Practice Q&A
• Panel Discussions 1–4

---

🏢 Practice & Advanced Learning

• Advancing Practice
• POD 1: Rheumatoid Arthritis Outcomes
• POD 2: Practice Advancement
• POD 3: Psoriatic Arthritis Decisions

---

🧬 Industry Showcases

• Virtual Showcase – Amgen
• Virtual Showcase – Eli Lilly
• Virtual Showcase – Genentech
• Virtual Showcase – Sanofi

---

🎬 Additional Sessions

• Welcome & Introduction
• Welcome & Introduction 2
• Closing Remarks & Adjourn
• Post-Reception Session

---

💡 Key Features

✔️ Complete 2026 rheumatology update
✔️ Evidence-based, clinically applicable content
✔️ Coverage of both common & complex autoimmune diseases
✔️ Insights into biologics and targeted therapies
✔️ Full multimedia package (videos + PDFs + subtitles)

---

🚀 Why This Course?

Stay ahead in rheumatology and:

• Improve management of complex autoimmune conditions
• Apply the latest treatment strategies with confidence
• Enhance clinical decision-making
• Access expert-level, up-to-date medical education

👉 A must-have resource for rheumatology professionals in 2026